Physical and Mechanobiological Basis of Biological Functions of Platelets

Abstract

Platelets play a unique role in thrombosis and hemostasis. Historical research has revealed biological mechanisms underlying various platelet functions. However, unraveling the complex mechanisms underlying various platelet functions is challenging. Recent progress in high-performance computer has enabled an understanding of the complex biological functions of platelets through combinations of basic principles of physics, such as Newton's laws of motion, fluid mechanics, and mechanobiology. Platelets are blood cells with diameters of 2 to 5 µm. They lack nuclei but contain organelles such as mitochondria. Platelets promptly adhere to the sites of endothelial damage for hemostasis. Adherent platelets are activated to allow plasma ligands of fibrinogen and von Willebrand factor (VWF) to bind stably to them. They also enhance local coagulant activity through their procoagulant activity. The specific biological functions of platelets are mediated by dynamic structural changes in their membrane proteins. Even lipids and proteins that mediate the specific functions of platelets are constructed from atoms following basic physical rules, such as Newton's laws of motion. Thus, the various biological functions of platelets can be constructed from physical principles, starting with the movement of atoms. Here, various complex biological functions of platelets were constructed using mathematical models and simple physical principles. This framework may help explain the complex pathophysiological mechanisms underlying the VWF–platelet interaction in both healthy and diseased conditions. Detailed quantitative biological experiments confirmed the validity of these mathematical models. The future direction of constructive “theoretical medicine and biology,” starting from atomic movements, is expected to follow.

Keywords

platelets - adhesion - von Willebrand factor - GPIbα - GPIIb/IIIa - molecular dynamic simulation - high-performance computer

Publikationsverlauf

Eingereicht: 31. März 2025

Angenommen: 18. Juli 2025

Accepted Manuscript online:
05. August 2025

Artikel online veröffentlicht:
20. August 2025

• References

• 1 Goto S, Hasebe T, Takagi S. Platelets: small in size but essential in the regulation of vascular homeostasis—translation from basic science to clinical medicine. Circ J 2015; 79 (09) 1871-1881
• 2 Italiano Jr JE, Bergmeier W, Tiwari S. et al. Mechanisms and implications of platelet discoid shape. Blood 2003; 101 (12) 4789-4796
• 3 Frojmovic MM, Milton JG. Human platelet size, shape, and related functions in health and disease. Physiol Rev 1982; 62 (01) 185-261
• 4 Goto S. Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents. Curr Vasc Pharmacol 2004; 2 (01) 23-32
• 5 Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (01) 327-358
• 6 Scridon A. Platelets and their role in hemostasis and thrombosis—from physiology to pathophysiology and therapeutic implications. Int J Mol Sci 2022; 23 (21) 12772
• 7 Smyth SS, McEver RP, Weyrich AS. et al; 2009 Platelet Colloquium Participants. Platelet functions beyond hemostasis. J Thromb Haemost 2009; 7 (11) 1759-1766
• 8 Sachs L, Denker C, Greinacher A, Palankar R. Quantifying single-platelet biomechanics: an outsider's guide to biophysical methods and recent advances. Res Pract Thromb Haemost 2020; 4 (03) 386-401
• 9 Bergal HT, Jiang Y, Yang D, Springer TA, Wong WP. Conformation of von Willebrand factor in shear flow revealed with stroboscopic single-molecule imaging. Blood 2022; 140 (23) 2490-2499
• 10 Thomas MR, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015; 114 (03) 449-458
• 11 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115 (12) 3378-3384
• 12 Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 2018; 122 (02) 337-351
• 13 Hagihara M, Higuchi A, Tamura N. et al. Platelets, after exposure to a high shear stress, induce IL-10-producing, mature dendritic cells in vitro. J Immunol 2004; 172 (09) 5297-5303
• 14 Goto S, Ichikawa N, Lee M. et al. Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow. Int Angiol 2000; 19 (02) 147-151
• 15 Tamura N, Yoshida M, Ichikawa N. et al. Shear-induced von Willebrand factor-mediated platelet surface translocation of the CD40 ligand. Thromb Res 2002; 108 (5-6): 311-315
• 16 Danese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 2005; 25 (02) 103-121
• 17 Freedman JE. CD40-CD40L and platelet function: beyond hemostasis. Circ Res 2003; 92 (09) 944-946
• 18 Zaid Y, Merhi Y. Implication of platelets in immuno-thrombosis and thrombo-inflammation. Front Cardiovasc Med 2022; 9: 863846
• 19 Goto S. Propagation of arterial thrombi: local and remote contributory factors. Arterioscler Thromb Vasc Biol 2004; 24 (12) 2207-2208
• 20 Popel AS, Johnson PC. Microcirculation and hemorheology. Annu Rev Fluid Mech 2005; 37: 43-69
• 21 Kawamura Y, Takahari Y, Tamura N. et al. Imaging of structural changes in endothelial cells and thrombus formation at the site of FeCl(3)-induced injuries in mice cremasteric arteries. J Atheroscler Thromb 2009; 16 (06) 807-814
• 22 André P, Denis CV, Ware J. et al. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 2000; 96 (10) 3322-3328
• 23 Lindqvist T, Fahraeus R. The viscosity of the blood in narrow capillary tubes. Am J Physiol-Legacy Content 1931; 96: 562-568
• 24 Herczyński R. Fåhræus effect revisited. Arch Mech 2016; 68 (01) 81-93
• 25 Taylor M, Robertson JS. The flow of blood in narrow tubes. I. A capillary microphotometer: an apparatus for measuring the optical density of flowing blood. Aust J Exp Biol Med Sci 1954; 32 (05) 721-732
• 26 Ii S, Sugiyama K, Takagi S. et al. A computational blood flow analysis in a capillary vessel including multiple red blood cells and platelets. J Biomech Sci Engrg 2012; 7(1): 72-83
• 27 Tamura N, Shimizu K, Shiozaki S. et al. Important regulatory roles of erythrocytes in platelet adhesion to the von Willebrand factor on the wall under blood flow conditions. Thromb Haemost 2022; 122 (06) 974-983
• 28 Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100 (12) 1673-1685
• 29 Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270 (40) 23352-23361
• 30 Vogel B, Claessen BE, Arnold SV. et al. ST-segment elevation myocardial infarction. Nat Rev Dis Primers 2019; 5 (01) 39
• 31 Goto S, Ikeda Y, Saldívar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101 (02) 479-486
• 32 Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99 (04) 559-564
• 33 McGrath RT, McRae E, Smith OP, O'Donnell JS. Platelet von Willebrand factor—structure, function and biological importance. Br J Haematol 2010; 148 (06) 834-843
• 34 Wagner DD. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70 (01) 105-110
• 35 Jones TR, Kao KJ, Pizzo SV, Bigner DD. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Am J Pathol 1981; 103 (02) 304-308
• 36 Zanetta L, Marcus SG, Vasile J. et al. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000; 85 (02) 281-288
• 37 Rand JH, Glanville RW, Wu X-X. et al. The significance of subendothelial von Willebrand factor. Thromb Haemost 1997; 78 (01) 445-450
• 38 Houdijk WP, de Groot PG, Nievelstein PF, Sakariassen KS, Sixma JJ. Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis 1986; 6 (01) 24-33
• 39 Nieswandt B, Brakebusch C, Bergmeier W. et al. Glycoprotein VI but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J 2001; 20 (09) 2120-2130
• 40 Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM. Isolation and characterization of a collagen binding domain in human von Willebrand factor. J Biol Chem 1986; 261 (32) 15310-15315
• 41 Shiozaki S, Ishikawa KL, Takagi S. Numerical study on platelet adhesion to vessel walls using the kinetic Monte Carlo method. Journal of Biomechanical Science and Engineering 2012; 7: 275-283
• 42 Shiozaki S, Takagi S, Goto S. Prediction of molecular interaction between platelet glycoprotein Ibα and von Willebrand factor using molecular dynamics simulations. J Atheroscler Thromb 2016; 23 (04) 455-464
• 43 Kim J, Zhang C-Z, Zhang X, Springer TA. A mechanically stabilized receptor-ligand flex-bond important in the vasculature. Nature 2010; 466 (7309) 992-995
• 44 Tobimatsu H, Nishibuchi Y, Sudo R, Goto S, Tanishita K. Adhesive forces between A1 domain of von Willebrand factor and N-terminus domain of glycoprotein Ibα measured by atomic force microscopy. J Atheroscler Thromb 2015; 22 (10) 1091-1099
• 45 Wang Y, Li Y, Zhang S. et al. Friction between a single platelet and fibrinogen. Friction 2024; 12: 2344-2354
• 46 Nakayama M, Goto S, Goto S. Effects of caplacizumab, a specific inhibitor of the A1 domain of von Willebrand factor binding with platelet membrane glycoprotein (GP) Ibα, on the length of platelet pseudopods supporting platelet adhesions on immobilized von Willebrand factor under blood flow condition. J Biorheol 2022; 36(2): 68-75
• 47 Savage B, Saldívar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84 (02) 289-297
• 48 Brooks BR, Brooks III CL, Mackerell Jr AD. et al. CHARMM: the biomolecular simulation program. J Comput Chem 2009; 30 (10) 1545-1614
• 49 Brooks BR, Bruccoleri RE, Olafson BD. et al. CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983; 4: 187-217
• 50 Zhu X, Lopes PE, Mackerell Jr AD. Recent developments and applications of the CHARMM force fields. Wiley Interdiscip Rev Comput Mol Sci 2012; 2 (01) 167-185
• 51 Pastor RW, Mackerell Jr AD. Development of the CHARMM force field for lipids. J Phys Chem Lett 2011; 2 (13) 1526-1532
• 52 Ruedenberg K. The physical nature of the chemical bond. Rev Mod Phys 1962; 34: 326
• 53 Goto S, Oka H, Ayabe K. et al. Prediction of binding characteristics between von Willebrand factor and platelet glycoprotein Ibα with various mutations by molecular dynamic simulation. Thromb Res 2019; 184: 129-135
• 54 Wang P, Sheriff J, Zhang P, Deng Y, Bluestein D. A multiscale model for shear-mediated platelet adhesion dynamics: correlating in silico with in vitro results. Ann Biomed Eng 2023; 51 (05) 1094-1105
• 55 Garcia-Cantu E, Spaulding C, Corcos T. et al. Stent implantation in acute myocardial infarction. Am J Cardiol 1996; 77 (07) 451-454
• 56 Grines CL, Cox DA, Stone GW. et al; Stent Primary Angioplasty in Myocardial Infarction Study Group. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341 (26) 1949-1956
• 57 Stone GW, Lansky AJ, Pocock SJ. et al; HORIZONS-AMI Trial Investigators. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009; 360 (19) 1946-1959
• 58 Spaulding C, Henry P, Teiger E. et al; TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006; 355 (11) 1093-1104
• 59 Eto K, Goto S, Shimazaki T. et al. Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets 2001; 12 (04) 228-235
• 60 Sakakibara M, Goto S, Eto K, Tamura N, Isshiki T, Handa S. Application of ex vivo flow chamber system for assessment of stent thrombosis. Arterioscler Thromb Vasc Biol 2002; 22 (08) 1360-1364
• 61 Tomita A, Tamura N, Nanazawa Y, Shiozaki S, Goto S. Development of virtual platelets implementing the functions of three platelet membrane proteins with different adhesive characteristics. J Atheroscler Thromb 2015; 22 (02) 201-210
• 62 Leiderman K, Fogelson AL. Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow. Math Med Biol 2011; 28 (01) 47-84
• 63 Shi X, Yang J, Huang J. et al. Effects of different shear rates on the attachment and detachment of platelet thrombi. Mol Med Rep 2016; 13 (03) 2447-2456
• 64 Jen CJ, Li HM, Wang J-S, Chen HI, Usami S. Flow-induced detachment of adherent platelets from fibrinogen-coated surface. Am J Physiol 1996; 270 (1 Pt 2): H160-H166
• 65 Fogelson AL. A mathematical model and numerical method for studying platelet adhesion and aggregation during blood clotting. J Comput Phys 1984; 56: 111-134
• 66 Goto S, Tamura N, Eto K, Ikeda Y, Handa S. Functional significance of adenosine 5′-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate. Circulation 2002; 105 (21) 2531-2536
• 67 Zucker M, Nachmias V. Platelet activation. Arteriosclerosis 1985; 5: 2-18
• 68 Niiya K, Hodson E, Bader R. et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 1987; 70 (02) 475-483
• 69 Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985; 260 (20) 11107-11114
• 70 Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74 (04) 1181-1195
• 71 Hartwig JH. Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118 (06) 1421-1442
• 72 Goto S, Tamura N, Ishida H, Ruggeri ZM. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5′-diphosphate receptor stimulation and cyclic calcium signaling. J Am Coll Cardiol 2006; 47 (01) 155-162
• 73 Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost 2009; 7 (07) 1057-1066
• 74 Rink TJ, Sage SO. Calcium signaling in human platelets. Annu Rev Physiol 1990; 52: 431-449
• 75 Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 1983; 258 (11) 6701-6704
• 76 Shattil SJ, Brugge JS. Protein tyrosine phosphorylation and the adhesive functions of platelets. Curr Opin Cell Biol 1991; 3 (05) 869-879
• 77 Nakayama M, Goto S, Goto S. Development of the integrated computer simulation model of the intracellular, transmembrane, and extracellular domain of platelet integrin α _IIb β ₃ (platelet membrane glycoprotein: GPIIb-IIIa). TH Open 2024; 8 (01) e96-e105
• 78 Calvete JJ. On the structure and function of platelet integrin α IIb β 3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995; 208 (04) 346-360
• 79 Bennett JS. Platelet-fibrinogen interactions. Ann N Y Acad Sci 2001; 936: 340-354
• 80 Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999; 353 (9148) 227-231
• 81 Adair BD, Yeager M. Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and x-ray crystallography. Proc Natl Acad Sci U S A 2002; 99 (22) 14059-14064
• 82 Xiao T, Takagi J, Coller BS, Wang JH, Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004; 432 (7013) 59-67
• 83 Wegener KL, Partridge AW, Han J. et al. Structural basis of integrin activation by talin. Cell 2007; 128 (01) 171-182
• 84 Moser M, Nieswandt B, Ussar S, Pozgajova M, Fässler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med 2008; 14 (03) 325-330
• 85 Galli M, Bevers EM, Comfurius P, Barbui T, Zwaal RF. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 1993; 83 (03) 466-472
• 86 Pasquet J-M, Toti F, Nurden AT, Dachary-Prigent J. Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res 1996; 82 (06) 509-522
• 87 Wood JP, Silveira JR, Maille NM, Haynes LM, Tracy PB. Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity. Blood 2011; 117 (05) 1710-1718
• 88 Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: physiological significance and mechanisms of exposure. Blood Rev 1991; 5 (03) 146-154
• 89 Miyazaki Y, Nomura S, Miyake T. et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88 (09) 3456-3464
• 90 Lentz BR. Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003; 42 (05) 423-438
• 91 Schoenwaelder SM, Yuan Y, Josefsson EC. et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114 (03) 663-666
• 92 van Kruchten R, Mattheij NJ, Saunders C. et al. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood 2013; 121 (10) 1850-1857
• 93 Goto S, Tamura N, Li M. et al. Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost 2003; 1 (09) 2022-2030
• 94 Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468 (7325) 834-838
• 95 Mizuno H, Fujimoto Z, Atoda H, Morita T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc Natl Acad Sci U S A 2001; 98 (13) 7230-7234
• 96 Sunnerhagen M, Forsén S, Hoffrén A-M, Drakenberg T, Teleman O, Stenflo J. Structure of the Ca(2+)-free Gla domain sheds light on membrane binding of blood coagulation proteins. Nat Struct Biol 1995; 2 (06) 504-509
• 97 Stenflo J. Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors. Crit Rev Eukaryot Gene Expr 1999; 9 (01) 59-88
• 98 Huang M, Rigby AC, Morelli X. et al. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 2003; 10 (09) 751-756
• 99 Majumder R, Quinn-Allen MA, Kane WH, Lentz BR. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex. Blood 2008; 112 (07) 2795-2802
• 100 Wang J, Yu C, Zhuang J. et al. The role of phosphatidylserine on the membrane in immunity and blood coagulation. Biomark Res 2022; 10 (01) 4
• 101 Spronk HM, ten Cate H, van der Meijden PE. Differential roles of tissue factor and phosphatidylserine in activation of coagulation. Thromb Res 2014; 133 (Suppl. 01) S54-S56
• 102 Goto S, Tamura N, Ayabe K. et al. A method and preliminary results of in silico computer simulation for the formation of mix thrombi with platelet and fibrin. Journal of Biorheology 2017; 31(2): 30-34
• 103 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 104 Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109 (12) 5087-5095
• 105 Kulkarni S, Dopheide SM, Yap CL. et al. A revised model of platelet aggregation. J Clin Invest 2000; 105 (06) 783-791
• 106 Goto S, Sakai H, Goto M. et al. Enhanced shear-induced platelet aggregation in acute myocardial infarction. Circulation 1999; 99 (05) 608-613
• 107 Ikeda Y, Handa M, Kawano K. et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991; 87 (04) 1234-1240
• 108 Goto S, Ikeda Y, Murata M. et al. Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation 1992; 86 (06) 1859-1863